News & Events

Read about the latest Gore news and events. Learn about innovative new products and technologies.
Categories

News

Article: The GORE-TEX Eye (Bloomberg Businessweek)

Posted May 13, 2019

Innovation is at the heart of Gore. You may know us for GORE-TEX jackets, ELIXIR guitar strings, medical devices and countless products for industrial applications, but we're always adding to the list. Read the article from Bloomberg Businessweek to learn more about Gore’s new ventures and how we are always advancing our technologies.

Press Release

GORE® ENFORM Biomaterial Earns Innovative Technology Designation from Vizient, Inc.

Posted July 17, 2019

W. L. Gore & Associates announced that GORE® ENFORM Biomaterial for use in abdominal wall reconstruction procedures recently received the Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the U.S.

Featured Story

Gore Tackles Tough Biopharma Challenge

Posted July 11, 2019

Have you ever dropped your new phone and cracked the screen? It’s never a good feeling to lose something of value. Now imagine if that something was worth thousands to millions of dollars and had the potential to change lives. That’s what drug manufacturers stand to lose if a single-use bulk drug storage bag — holding biologic substances — is damaged. A new solution from Gore addresses this issue.

Press Release

First U.S. Patient Receives GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL

Posted July 10, 2019

Gore announces the first U.S. implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. This first case follows the recent FDA approval for this new device.

News

Article: Expanding the Scope of Single-Use Technologies

Posted July 2, 2019

Single-use systems increasingly need to withstand the rigors of cold chain handling at -40°C to -80°C, particularly for packaging valuable bulk drug product for shipment. Read the article in Genetic Engineering to learn more about how Gore is helping to advance single-use technology in the pharmaceutical space.

Press Release

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

Posted June 4, 2019

W. L. Gore & Associates announced the U.S. Food and Drug Administration’s (FDA’s) premarket approval (PMA) of the GORE® CARDIOFORM ASD Occluder for the percutaneous closure of ostium secundum atrial septal defects (ASDs).

Press Release

Gore Receives FDA Approval for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL

Posted May 15, 2019

W. L. Gore & Associates, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for commercial distribution for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System, a unique Thoracic Endovascular Aortic Repair (TEVAR) solution combining new levels of control with the proven legacy and trusted performance of the Conformable GORE® TAG® Device.

Press Release

Gore Attending Two Upcoming Biopharmaceutical Conferences in April

Posted March 22, 2019

Visit Booth 70 at BPI Europe in Vienna and Booth 3737 at Interphex in New York City to learn how Gore's innovative technologies help biopharmaceutical manufacturers achieve efficiency and operate reliably.

News

New Container Protects Bulk Frozen Biopharmaceuticals

Posted March 19, 2019

Trends in the biopharmaceuticals market prompted the development of a new high-performance pouch that addresses the mechanical and purity challenges of packaging bulk drug product at low temperatures. The GORE® STA-PURE™ Flexible Freeze Container maintains package integrity after freezing at -86° C (-123° F) and it's durable design minimizes product loss due to package failure.

Press Release

Gore to Showcase GORE® ENFORM Biomaterial - A New Synthetic and Absorbable Biomaterial for Abdominal Wall Reconstruction - at the American Hernia Society (AHS) Annual Meeting

Posted March 5, 2019

W. L. Gore & Associates, Inc. (Gore) will showcase its new GORE® ENFORM Biomaterial, a fully synthetic and absorbable biomaterial designed for optimal handling and tissue response, at the AHS annual meeting in Las Vegas on March 11-14, 2019.

Press Release

GORE® TIGRIS® Vascular Stent Demonstrates High Patency Rates at 12 Months in Treating SFA and PPA Occlusive Lesions in Challenging Patients

Posted January 24, 2019

The GORE® TIGRIS® Vascular Stent demonstrated that it is a safe and effective device that can be incorporated into a modern “leave-nothing-behind” treatment algorithm that reserves stent usage for more challenging patients.

Press Release

Gore Celebrates 15th Anniversary of Market-Leading GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement

Posted November 12, 2018

W. L. Gore & Associates, Inc. (Gore) is celebrating the 15th Anniversary of its GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement, a synthetic buttressing material engineered to reduce leaks and bleeding in a variety of minimally-invasive weight loss procedures, including sleeve gastrectomy and gastric bypass.

Press Release

Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium®

Posted November 8, 2018

W. L. Gore & Associates, Inc. (Gore) will highlight data gleaned from its Global Registry for Endovascular Aortic Treatment (GREAT) Study at the 45th Annual Symposium on Vascular and Endovascular Issues, VEITHsymposium® in New York.

Load more news